Skip to main content

Table 3 GLM model for 4-week validated quit; adjusted odds ratios with 95 % confidence intervals (CI) and significance results

From: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service

Variable

Level

Quit rate – n/N (%)

Odds ratio (95 % CI)

Wald (d.f.)

p-value

Sex

   

6.7 (1)

0.01

Male

1763/3055 (57.7 %)

1

  

Female

2133/3904 (54.6 %)

0.88 (0.79–0.97)

 

0.03

Region

   

192.9 (3)

<0.001

East Sussex

2431/3773 (64.4 %)

1

  

Sandwell

1069/2331 (45.9 %)

0.49 (0.44–0.55)

 

<0.001

Walsall

57/140 (40.7 %)

0.38 (0.27–0.54)

 

<0.001

Worcestershire

339/715 (47.4 %)

0.48 (0.40–0.57)

 

<0.001

Age

   

53.5 (4)

<0.001

12–19

148/426 (34.7 %)

1

  

20–29

553/1041 (53.1 %)

1.79 (1.39–2.31)

 

<0.001

30–49

1690/2963 (57.0 %)

2.12 (1.68–2.68)

 

<0.001

50–69

1275/2158 (59.1 %)

2.30 (1.80–2.92)

 

<0.001

70+

230/371 (62.0 %)

2.47 (1.81–3.37)

 

<0.001

Counselling

   

71.7 (6)

<0.001

One-to-one

3315/5666 (58.5 %)

1

  

Drop-in

148/350 (42.3 %)

1.14 (0.88–1.47)

 

0.4

GP

155/326 (47.5 %)

0.89 (0.70–1.14)

 

0.2

Pharmacy

82/207 (39.6 %)

0.55 (0.41–0.73)

 

<0.001

Nurse

64/165 (38.8 %)

0.31 (0.22–0.42)

 

<0.001

Telephone

108/185 (58.4 %)

1.01 (0.75–1.37)

 

0.6

Other

24/57 (42.1 %)

0.55 (0.32–0.94)

 

0.02

Treatment

   

19.0 (1)

<0.001

NRT

3340/6085 (54.9 %)

1

  

Varenicline

556/874 (63.6 %)

1.41

 

<0.001